APA (7th ed.) Citation

Angela, Y., Haferkamp, S., Weishaupt, C., Ugurel, S., Becker, J. C., Oberndörfer, F., . . . Gutzmer, R. (2019). Combination of denosumab and immune checkpoint inhibition: Experience in 29 patients with metastatic melanoma and bone metastases. Cancer Immunology, Immunotherapy, 68(7), 1187-1194. https://doi.org/10.1007/s00262-019-02353-5

Chicago Style (17th ed.) Citation

Angela, Yenny, Sebastian Haferkamp, Carsten Weishaupt, Selma Ugurel, Jürgen C. Becker, Florian Oberndörfer, Vesna Alar, Imke Satzger, and Ralf Gutzmer. "Combination of Denosumab and Immune Checkpoint Inhibition: Experience in 29 Patients with Metastatic Melanoma and Bone Metastases." Cancer Immunology, Immunotherapy 68, no. 7 (2019): 1187-1194. https://doi.org/10.1007/s00262-019-02353-5.

MLA (9th ed.) Citation

Angela, Yenny, et al. "Combination of Denosumab and Immune Checkpoint Inhibition: Experience in 29 Patients with Metastatic Melanoma and Bone Metastases." Cancer Immunology, Immunotherapy, vol. 68, no. 7, 2019, pp. 1187-1194, https://doi.org/10.1007/s00262-019-02353-5.